Roswell Biotechnologies

About:

Revolutionizing Reading DNA through Molecular Electronics

Website: https://www.roswellbiotech.com/

Twitter/X: RoswellBiotech

Top Investors: Justin Mateen

Description:

Roswell Biotechnologies is a molecular electronics company transforming DNA sequencing with their latest platform, designed to deliver the disruptive performance required for future biomedical and industrial applications. The platform technology, ENDSeq™ (Electronic Nano-Device Sequencing), deploys single molecule sensor nanotechnology in a scalable semiconductor chip format, to deliver a dramatic reduction in the cost of genome-sequencing with unprecedented speed, accuracy and simplicity. Roswell is focused on delivering the molecular electronics chip and system that provides a $100, 1-hour whole human genome for use in precision medicine.

Total Funding Amount:

$37M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

San Diego, California, United States

Founded Date:

2014-06-01

Contact Email:

info(AT)RoswellBiotech.com

Founders:

Barry Merriman, Paul W Mola

Number of Employees:

11-50

Last Funding Date:

2019-01-03

IPO Status:

Private

Industries:

© 2025 bioDAO.ai